ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

BDTX Black Diamond Therapeutics Inc

4.74
-0.30 (-5.95%)
After Hours
Last Updated: 17:05:48
Delayed by 15 minutes

Period:

Draw Mode:

Volume 509,796
Bid Price 4.61
Ask Price 4.84
News -
Day High 5.04

Low
1.62

52 Week Range

High
7.66

Day Low 4.61
Company Name Stock Ticker Symbol Market Type
Black Diamond Therapeutics Inc BDTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.30 -5.95% 4.74 17:05:48
Open Price Low Price High Price Close Price Prev Close
5.03 4.61 5.04 4.74 5.04
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,902 509,796 $ 4.78 $ 2,434,844 - 1.62 - 7.66
Last Trade Time Type Quantity Stock Price Currency
17:17:03 3 $ 4.84 USD

Black Diamond Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
245.14M 51.72M - 0 -82.44M -1.59 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Black Diamond Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BDTX Message Board. Create One! See More Posts on BDTX Message Board See More Message Board Posts

Historical BDTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.445.544.615.031,103,243-0.70-12.87%
1 Month4.977.664.615.85970,720-0.23-4.63%
3 Months5.227.663.725.43665,943-0.48-9.20%
6 Months2.317.662.1554.59606,8062.43105.19%
1 Year1.867.661.625.251,505,3742.88154.84%
3 Years13.5014.181.185.49690,800-8.76-64.89%
5 Years33.0046.251.189.28576,047-28.26-85.64%

Black Diamond Therapeutics Description

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under pipeline are BDTX-189 and BDTX-1535.